Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
01 1Interquim, S.A. de C.V.
02 1ANUH PHARMA LIMITED
03 1Aurobindo Pharma Limited
04 1DARMERICA, LLC
05 1Fukuzyu Pharmaceutical Co., Ltd
06 1HIKAL LIMITED
07 1Ipca Laboratories Limited
08 1Kalchem International inc
09 1Professional Compounding Centers of America
10 2R.L.Fine Chem Private Limited
01 5PYRIMETHAMINE
02 6Pyrimethamine
01 6India
02 1Japan
03 1Spain
04 2U.S.A
05 1United Kingdom
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
NDC Package Code : 40074-0008
Start Marketing Date : 2021-09-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64677-0006
Start Marketing Date : 2022-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-564
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-215
Start Marketing Date : 2019-07-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5000g/5000g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68057-001
Start Marketing Date : 2013-08-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66651-922
Start Marketing Date : 2017-12-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-1183
Start Marketing Date : 2019-11-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60592-244
Start Marketing Date : 2019-12-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0237
Start Marketing Date : 2022-03-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 71554-020
Start Marketing Date : 2020-10-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Daraprim manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Daraprim, including repackagers and relabelers. The FDA regulates Daraprim manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Daraprim API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Daraprim manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Daraprim supplier is an individual or a company that provides Daraprim active pharmaceutical ingredient (API) or Daraprim finished formulations upon request. The Daraprim suppliers may include Daraprim API manufacturers, exporters, distributors and traders.
click here to find a list of Daraprim suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Daraprim as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Daraprim API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Daraprim as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Daraprim and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Daraprim NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Daraprim suppliers with NDC on PharmaCompass.
We have 10 companies offering Daraprim
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
